During the past decade, Shenzhen Donghu Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Shenzhen Donghu Hospital" are "Hepatitis B, Chronic" (3 trials). Many other conditions were trialed in "Shenzhen Donghu Hospital" in a lesser frequency.

Most popular intervention types in "Shenzhen Donghu Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Peg-IFN alfa-2a" (1 trials) and "Pegylated Interferon Alfa (Peginterferon Alfa)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shenzhen Donghu Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Shenzhen Donghu Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Shenzhen Donghu Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shenzhen Donghu Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".